JPRN-UMIN000009562已完成未知
Evaluation of the efficacy and safety for switching from premixed insulin to ultra-long acting insulin plus ultra-rapid insulin - Evaluation of the efficacy and safety for ultra-long acting insulin plus ultra-rapid insulin
Department of Endocrinology and Metabolism, Nagoya City West Medical Center0 个研究点目标入组 40 人开始时间: 2012年12月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.patients who need insulin therapy newly during this study 2.patients who have allergy for insulin glargine or glulisine 3.patients who had suffered from severe ketosis and diabetic coma or pre-coma 4.patients with serious infection, inflammation, or injury pre- or post- operative state 5.patients who are pregnant, hope to be pregnant, or are in lactation period 6.patients had suffered from drug-induced muscle disorder 7.drug abuser or heavy alcohol drinker
研究者
相似试验
已完成
不适用
Investigation of efficacy and safety of switching from basal-bolus therapy to combination therapy with GLP-1 receptor agonist and basal insulin injection in type 2 diabetestype 2 diabetesJPRN-UMIN000013222Juntendo University Graduate School of Medicine30
尚未招募
Unknown
Study of the effectiveness and safety of switching from JAK inhibitors to non-TNF biologics in elderly patients with rheumatoid arthritisRheumatoid arthritisJPRN-UMIN000050387Kawasaki Medical School30
已完成
不适用
Prospective study of effecacy and safety of switch from oral medicine of tramadolto fentanyl sticking medicine (dyuroteppu MT patch on the 3rd) in lung cancer and malignant pleura mesothelioma with the pailung cancer, malignant mesotheliomaJPRN-UMIN000005620Osaka Prefectural Medical Center for Respiratory and Allergic Diseases15
进行中（未招募）
1 期
Assessing the safety and efficacy of switching to Azarga (Brinzolamide/Timolol Fixed Combination), as replacement therapy in patients with uncontrolled intraocular pressure - not applicableEUCTR2009-015795-10-SIAlcon d.o.o.120
招募中
1 期
Evaluating efficacy and safety of switching a boosted protease inhibitor to fostemsavir in PLWH with limited therapeutic options (FOST Switch)HIV-1MedDRA version: 20.1Level: LLTClassification code: 10020172Term: HIV infection NOS Class: 10021881CTIS2023-504192-25-00EAT ID Foundation60